Dactinomycin composition and method for treating myelodysplastic syndrome and acute myeloid leukemia

摘要

The present disclosure discloses a composition comprising dactinomycin formulated with nanoparticles for delivery and myelodysplastic syndrome (MDS) or cancer, eg, NPM1-mutant acute myeloid leukemia (AML). And a method of treatment by administration of the composition.